Cardinal Health (NYSE:CAH) Issues FY 2025 Earnings Guidance

Cardinal Health (NYSE:CAH) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share guidance of 7.900-7.900 for the period, compared to the consensus earnings per share estimate of 8.720. The company issued revenue guidance of -.

Cardinal Health Stock Performance

NYSE CAH opened at $126.27 on Friday. The firm’s 50 day moving average price is $120.75 and its two-hundred day moving average price is $111.92. Cardinal Health has a twelve month low of $93.17 and a twelve month high of $127.27. The stock has a market cap of $30.56 billion, a price-to-earnings ratio of 24.57, a PEG ratio of 1.48 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health’s quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.73 earnings per share. On average, research analysts forecast that Cardinal Health will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were paid a $0.5056 dividend. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. Cardinal Health’s dividend payout ratio (DPR) is currently 39.30%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on CAH shares. Deutsche Bank Aktiengesellschaft lifted their price target on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday, November 4th. Citigroup increased their price objective on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a report on Friday, January 10th. Morgan Stanley lifted their price target on shares of Cardinal Health from $127.00 to $136.00 and gave the company an “overweight” rating in a research report on Tuesday, December 17th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. Finally, StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $133.29.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.